Vineet Laboratories's EBIT per Share for the
three
months ended in Dec. 2025 was ₹2.07.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was ₹-2.35.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Vineet Laboratories's EBIT per Share or its related term are showing as below:
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Vineet Laboratories was -9.60% per year. The lowest was -9.60% per year. And the median was -9.60% per year.
NSE:VINEETLAB's 3-Year EBIT Growth Rate is not ranked *
in the Chemicals industry.
Industry Median: -1.15 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Vineet Laboratories (NSE:VINEETLAB) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Vineet Laboratories EBIT per Share Related Terms
Vineet Laboratories EBIT per Share Historical Data
* Premium members only.
The historical data trend for Vineet Laboratories's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-2.35
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vineet Laboratories (NSE:VINEETLAB) has a EBIT per Share of ₹-2.35 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vineet Laboratories and its competitors. According to the industry distribution chart, Vineet Laboratories ranks #999999 out of 1336 companies in the Chemicals industry.
Is Vineet Laboratories' EBIT per Share too high?
Vineet Laboratories' current EBIT per Share is ₹-2.35. Based on the distribution chart, Vineet Laboratories ranks #999999 out of 1336 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Vineet Laboratories has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' EBIT per Share compare to DOW?
According to the Chemicals industry distribution chart, Vineet Laboratories ranks #999999 out of 1336 companies for EBIT per Share. This places Vineet Laboratories in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vineet Laboratories and its competitors. Vineet Laboratories's current EBIT per Share is ₹-2.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.33, compared to a current price of ₹33.82 — trading 120.6% above its estimated fair value. The current EBIT per Share is ₹-2.35. Vineet Laboratories' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current EBIT per Share is ₹-2.35 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued.
The current stock price of ₹33.82 is trading 120.6% above its estimated GF Value™ of ₹15.33.
GuruFocus considers Vineet Laboratories to be Significantly Overvalued.
Key valuation signals for NSE:VINEETLAB:
EBIT per Share: ₹-2.35
GF Value™: ₹15.33 vs. price of ₹33.82 (120.6% above fair value)
No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
49GF Score
Get the complete analysis for NSE:VINEETLAB
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VINEETLAB has been successfully added to your 
